Case Report
J Rheum Dis 2011; 18(4): 320-323
Published online December 30, 2011
© Korean College of Rheumatology
Infliximab으로 치료한 류마티스관절염 환자에서 발생한 결핵성 복막염 1예
김인태1ㆍ박형복1ㆍ이상헌1ㆍ현여경1ㆍ김윤지1ㆍ이용원1ㆍ송정수2ㆍ최상태2
관동대학교 의과대학 내과학교실1, 중앙대학교 의과대학 내과학교실2
Tuberculous Peritonitis in a Patient with Rheumatoid Arthritis Treated with Infliximab
Correspondence to : Sang Tae Choi
One of the severe adverse reactions to anti-tumor necrosis factor (TNF)-Ձ therapy is the reactivation of tuberculosis. We present a case of tuberculous peritonitis in a 57-year- old woman with rheumatoid arthritis (RA) that appeared during treatment with infliximab. Confirming a diagnosis of tuberculous peritonitis is difficult and can be delayed because of the nonspecific symptoms, the rarity of the disease, and the low detection rate of mycobacteria in ascites fluid. This case illustrates that prompt anti-tuberculous therapy is needed for suspected cases of tuberculous peritonitis in RA patients treated with infliximab.
Keywords Infliximab, Tuberculous peritonitis, Anti-TNF therapy, Rheumatoid arthritis
PDF
Standard view
Export citation
Share Article
Case Report
J Rheum Dis 2011; 18(4): 320-323
Published online December 30, 2011
Copyright © Korean College of Rheumatology.
Infliximab으로 치료한 류마티스관절염 환자에서 발생한 결핵성 복막염 1예
김인태1ㆍ박형복1ㆍ이상헌1ㆍ현여경1ㆍ김윤지1ㆍ이용원1ㆍ송정수2ㆍ최상태2
관동대학교 의과대학 내과학교실1, 중앙대학교 의과대학 내과학교실2
Tuberculous Peritonitis in a Patient with Rheumatoid Arthritis Treated with Infliximab
In Tae Kim1, Hyung Bok Park1, Sang Hun Lee1, Yu Kyung Hyun1, Yun Ji Kim1, Yong Won Lee1, Jung-Soo Song2, Sang Tae Choi2
Department of Internal Medicine, Kwandong University College of Medicine1, Goyang, Department of Internal Medicine, Chung-Ang University College of Medicine2, Seoul, Korea
Correspondence to:Sang Tae Choi
Abstract
One of the severe adverse reactions to anti-tumor necrosis factor (TNF)-Ձ therapy is the reactivation of tuberculosis. We present a case of tuberculous peritonitis in a 57-year- old woman with rheumatoid arthritis (RA) that appeared during treatment with infliximab. Confirming a diagnosis of tuberculous peritonitis is difficult and can be delayed because of the nonspecific symptoms, the rarity of the disease, and the low detection rate of mycobacteria in ascites fluid. This case illustrates that prompt anti-tuberculous therapy is needed for suspected cases of tuberculous peritonitis in RA patients treated with infliximab.
Keywords: Infliximab, Tuberculous peritonitis, Anti-TNF therapy, Rheumatoid arthritis
Article Tools
Stats or Metrics
Share this article on
Related articles in JRD
-
A Case of Infliximab-induced Multifocal Motor Neuropathy in a Patient with Rheumatoid Arthritis and Literature Review
Bomi Seo, Yeong Jin Jeong, Seokchan Hong, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo
J Rheum Dis 2016; 23(4): 250-255 -
A Case of Atrial Fibrillation Induced by Infliximab in a Patient with Rheumatoid Arthritis
Jong-Wook Choi, Hye-Jin Tae, Il-Hwan Oh, Min-Kyu Lee, Jin-Ho Shin, Tae-Hwan Kim, Jae-Bum Jun, Wan-Sik Uhm
J Rheum Dis 2011; 18(4): 302-305 -
A Case of Bullous Pemphigoid Arising after Infliximab Therapy in a Patient with Rheumatoid Arthritis
Seong Oh Park, Ji Hyun Lee
The Journal of the Korean Rheumatism Association 2010; 17(4): 422-425
